Horman J T, Rullán J V, Myers R A, Bond J O, Israel E, Joseph J M
J Am Vet Med Assoc. 1987 Jul 15;191(2):185-7.
A study was undertaken to evaluate the effectiveness of a low dose of rabies human diploid cell vaccine administered intradermally for preexposure booster inoculation. Seventy-six volunteers received a 0.1-ml dose of rabies human diploid cell vaccine intradermally, approximately 2 years after their primary series. Though only 25 (32.9%) had a titer less than 0.5 IU/ml before the booster, all had a postbooster titer of greater than or equal to 4.0 IU/ml 3 weeks later. Five of 73 (6.8%) reported an allergic reaction after the booster.
开展了一项研究，以评估低剂量人用狂犬病二倍体细胞疫苗皮内注射用于暴露前加强接种的有效性。76名志愿者在完成基础免疫系列接种约2年后，接受了0.1毫升人用狂犬病二倍体细胞疫苗皮内注射。尽管在加强接种前只有25人（32.9%）的抗体滴度低于0.5 IU/ml，但3周后所有受试者加强接种后的抗体滴度均大于或等于4.0 IU/ml。73名受试者中有5人（6.8%）在加强接种后报告了过敏反应。
